Martingale Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-25,206
Closed -$453K 1055
2020
Q3
$453K Sell
25,206
-32,300
-56% -$557K 0.01% 836
2020
Q2
$949K Hold
57,506
0.01% 741
2020
Q1
$743K Buy
57,506
+1,200
+2% +$19.6K 0.01% 740
2019
Q4
$1.04M Buy
56,306
+13,900
+33% +$231K 0.01% 760
2019
Q3
$748K Buy
+42,406
New +$726K 0.01% 819

Other funds holding ASTH

Martingale Asset Management's ASTH Position: Q4 2020 in Review

Martingale Asset Management sold out of Astrana Health (ASTH) in Q4 2020, closing a stake of 25,206 shares — an estimated $453K sold.

Martingale Asset Management first reported a position in ASTH in Q3 2019 and held it in 5 quarters. The position peaked at $1.04M in Q4 2019. 62 funds tracked by Wall St. Rank hold ASTH as of Q4 2020.

  • Martingale Asset Management reported no remaining Astrana Health position as of Q4 2020 after selling out during the quarter.
  • Martingale Asset Management sold 25,206 Astrana Health shares in Q4 2020, an estimated $453K.
  • Martingale Asset Management first reported a position in Astrana Health in Q3 2019 and held it in 5 quarters.
  • Martingale Asset Management's Astrana Health position peaked at $1.04M in Q4 2019.
  • 62 funds tracked by Wall St. Rank held Astrana Health as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.